.png)
.png)
Report Library
View More
Datamonitor Healthcare I&I Disease ...
June 17, 2021
Datamonitor Healthcare Oncology: Pa...
June 17, 2021
Datamonitor Healthcare Oncology: Sm...
June 16, 2021
Datamonitor Healthcare CNS: Neuropa...
June 16, 2021
Datamonitor Healthcare I&I: Osteoar...
June 16, 2021
Datamonitor Healthcare CV&Met: Veno...
June 15, 2021
Datamonitor Healthcare I&I: Opioid-...
June 15, 2021
Datamonitor Healthcare I&I: Glaucom...
June 15, 2021
Datamonitor Healthcare Infectious D...
June 14, 2021
Datamonitor Healthcare I&I: Gout Ma...
June 14, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 6/16/21 | Regeneron (REGN) | REGEN-COV for COVID-19 Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/16/21 | Pfizer (PFE) | Xeljanz/Xeljanz XR for COVID-19 Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/16/21 | Altimmune (ALT) | ALT-801 for Non-Alcoholic Steatohepatitis (NASH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/16/21 | Aprea (APRE) | Eprenetapopt for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/15/21 | Sage Therapeutics (SAGE) | SAGE-217 for Major Depressive Disorder (MDD) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 06/19/21 | Subscribers Only | Subscribers Only | Trial Data - Other |
| Now - 06/20/21 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| Now - 06/20/21 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 06/20/21 | Subscribers Only | Subscribers Only | Trial Data - Other |
